| - GRCh37:
- Chr9:36276916
- GRCh38:
- Chr9:36276919
| GNE | R9T | Sialuria, GNE myopathy | Uncertain significance (Jun 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36229008-36236991
| GNE | | GNE myopathy, Sialuria | Likely pathogenic (Oct 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246018-36249404
| GNE | | GNE myopathy, Sialuria | Likely pathogenic (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36227225-36276941
| GNE | | GNE myopathy, Sialuria | Pathogenic (Sep 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246008-36276941
| GNE | | GNE myopathy, Sialuria | Pathogenic (Feb 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246018-36246489
| GNE | | GNE myopathy, Sialuria | Pathogenic (Nov 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249182
- GRCh38:
- Chr9:36249185
| GNE | | GNE myopathy, Sialuria | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36234059
- GRCh38:
- Chr9:36234062
| GNE | | GNE myopathy, Sialuria | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222928
- GRCh38:
- Chr9:36222931
| GNE | Q383H, Q434H, Q442H, Q493H, Q524H | GNE myopathy, Sialuria | Uncertain significance (Aug 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222897
- GRCh38:
- Chr9:36222900
| GNE | L394V, L445V, L453V, L504V, L535V | Sialuria, GNE myopathy | Uncertain significance (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223404
- GRCh38:
- Chr9:36223407
| GNE | E400D, E408D, E459D, E490D, E349D | GNE myopathy, Sialuria | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249275
- GRCh38:
- Chr9:36249278
| GNE | | GNE myopathy, Sialuria | Likely benign (May 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222868
- GRCh38:
- Chr9:36222871
| GNE | W403*, W544*, W454*, W462*, W513* | Sialuria, GNE myopathy, not provided
| Pathogenic (Sep 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:36249173
- GRCh38:
- Chr9:36249176
| GNE | | Sialuria, GNE myopathy | Likely benign (Jun 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36220028
- GRCh38:
- Chr9:36220031
| GNE | | Sialuria, GNE myopathy | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246039
- GRCh38:
- Chr9:36246042
| GNE | R143H, R202H, R233H | Sialuria, GNE myopathy | Uncertain significance (Jan 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223518
- GRCh38:
- Chr9:36223521
| GNE | | Sialuria, GNE myopathy | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36227399
- GRCh38:
- Chr9:36227402
| GNE | S266F, S407F, S317F, S376F, S325F | Sialuria, GNE myopathy | Uncertain significance (Oct 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249251
- GRCh38:
- Chr9:36249254
| GNE | | Sialuria, GNE myopathy | Likely benign (Oct 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219919
- GRCh38:
- Chr9:36219922
| GNE | D468H, D519H, D578H, D504H, D609H, D527H | GNE myopathy, Sialuria | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219991
- GRCh38:
- Chr9:36219994
| GNE | H480Y, H585Y, H444Y, H554Y, H503Y, H495Y | Sialuria, GNE myopathy, Inborn genetic diseases
| Conflicting interpretations of pathogenicity (May 26, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr9:36234020
- GRCh38:
- Chr9:36234023
| GNE | | GNE myopathy, Sialuria | Likely benign (Mar 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223516-36223517
- GRCh38:
- Chr9:36223519-36223520
| GNE | | Sialuria, GNE myopathy | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36234055
- GRCh38:
- Chr9:36234058
| GNE | V282I, V172I, V223I, V231I, V313I | Sialuria, GNE myopathy | Uncertain significance (Jun 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217371
- GRCh38:
- Chr9:36217374
| GNE | | GNE myopathy, Sialuria | Likely benign (Dec 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36276880
- GRCh38:
- Chr9:36276883
| GNE | | Sialuria, GNE myopathy | Likely benign (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217381
- GRCh38:
- Chr9:36217384
| GNE | T643R, T748R, T666R, T658R, T607R, T717R | Sialuria, GNE myopathy | Uncertain significance (Aug 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222993
- GRCh38:
- Chr9:36222996
| GNE | I413V, I421V, I503V, I362V, I472V | Sialuria, GNE myopathy | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36227235
- GRCh38:
- Chr9:36227238
| GNE | | Sialuria, GNE myopathy | Likely benign (Jun 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246024
- GRCh38:
- Chr9:36246027
| GNE | | Sialuria, GNE myopathy | Uncertain significance (Apr 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219896
- GRCh38:
- Chr9:36219899
| GNE | | Sialuria, GNE myopathy | Likely benign (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249246
- GRCh38:
- Chr9:36249249
| GNE | P36H, P67H | Sialuria, GNE myopathy | Uncertain significance (Aug 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223513-36223514
- GRCh38:
- Chr9:36223516-36223517
| GNE | | GNE myopathy, Sialuria | Likely benign (Oct 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246088
- GRCh38:
- Chr9:36246091
| GNE | Y217H, Y127H, Y186H | GNE myopathy, Sialuria | Pathogenic (Jan 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236976
- GRCh38:
- Chr9:36236979
| GNE | D208N, D149N, D239N | GNE myopathy, Sialuria | Likely pathogenic (Jul 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217507
- GRCh38:
- Chr9:36217510
| GNE | Y565C, Y706C, Y601C, Y616C, Y624C, Y675C | GNE myopathy, Sialuria | Uncertain significance (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219827
- GRCh38:
- Chr9:36219830
| GNE | | GNE myopathy, Sialuria | Likely benign (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236864
- GRCh38:
- Chr9:36236867
| GNE | K186T, K245T, K276T | not provided, GNE myopathy, Sialuria
| Uncertain significance (May 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr9:36229113
- GRCh38:
- Chr9:36229116
| GNE | | GNE myopathy, Sialuria | Likely benign (May 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249241
- GRCh38:
- Chr9:36249244
| GNE | F69L, F38L | Sialuria, GNE myopathy | Uncertain significance (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217541
- GRCh38:
- Chr9:36217544
| GNE | | Sialuria, GNE myopathy | Pathogenic (Apr 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36229050
- GRCh38:
- Chr9:36229053
| GNE | | Sialuria, GNE myopathy | Likely benign (Apr 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36276920
- GRCh38:
- Chr9:36276923
| GNE | Q8* | Sialuria, GNE myopathy | Pathogenic (Apr 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249358
- GRCh38:
- Chr9:36249361
| GNE | Q30K | Sialuria, GNE myopathy | Uncertain significance (Apr 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36218314
- GRCh38:
- Chr9:36218317
| GNE | | Sialuria, GNE myopathy | Likely benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223501-36223502
- GRCh38:
- Chr9:36223504-36223505
| GNE | | Sialuria, GNE myopathy | Uncertain significance (Mar 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246401
- GRCh38:
- Chr9:36246404
| GNE | | Sialuria, GNE myopathy | Likely benign (Mar 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223458
- GRCh38:
- Chr9:36223461
| GNE | | Sialuria, GNE myopathy | Likely benign (Sep 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36218241
- GRCh38:
- Chr9:36218244
| GNE | | Sialuria, GNE myopathy | Likely benign (Mar 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222919
- GRCh38:
- Chr9:36222922
| GNE | | Sialuria, GNE myopathy | Likely benign (Mar 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217396
- GRCh38:
- Chr9:36217399
| GNE | M661fs, M653fs, M638fs, M602fs, M712fs, M743fs | Sialuria, GNE myopathy | Pathogenic (Mar 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223515-36223516
- GRCh38:
- Chr9:36223518-36223519
| GNE | | GNE myopathy, Sialuria | Likely benign (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219892
- GRCh38:
- Chr9:36219895
| GNE | I528V, I477V, I587V, I618V, I513V, I536V | GNE myopathy, Sialuria | Uncertain significance (Feb 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249252
- GRCh38:
- Chr9:36249255
| GNE | T34S, T65S | GNE myopathy, Sialuria | Uncertain significance (Mar 18, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223394
- GRCh38:
- Chr9:36223397
| GNE | | GNE myopathy, Sialuria | Likely benign (Feb 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222835
- GRCh38:
- Chr9:36222838
| GNE | | GNE myopathy, Sialuria | Likely benign (Jan 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36218300
- GRCh38:
- Chr9:36218303
| GNE | | GNE myopathy, Sialuria | Likely benign (Jan 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236848
- GRCh38:
- Chr9:36236851
| GNE | | GNE myopathy, Sialuria | Likely benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36220023
- GRCh38:
- Chr9:36220026
| GNE | | GNE myopathy, Sialuria | Likely benign (Dec 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249368
- GRCh38:
- Chr9:36249371
| GNE | | Sialuria, GNE myopathy | Likely benign (Jun 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246391
- GRCh38:
- Chr9:36246394
| GNE | V116M, V26M, V85M | GNE myopathy, Sialuria | Uncertain significance (Jul 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249360
- GRCh38:
- Chr9:36249363
| GNE | K29T | GNE myopathy, Sialuria | Uncertain significance (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222966
- GRCh38:
- Chr9:36222969
| GNE | R371W, R422W, R430W, R512W, R481W | Sialuria, GNE myopathy | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222887
- GRCh38:
- Chr9:36222890
| GNE | T397I, T456I, T507I, T538I, T448I | Sialuria, GNE myopathy | Uncertain significance (Oct 5, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217451
- GRCh38:
- Chr9:36217454
| GNE | V620M, V694M, V725M, V584M, V643M, V635M | GNE myopathy, Sialuria | Uncertain significance (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246096
- GRCh38:
- Chr9:36246099
| GNE | C183S, C214S, C124S | Sialuria, GNE myopathy | Uncertain significance (May 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246281
- GRCh38:
- Chr9:36246284
| GNE | | Sialuria, GNE myopathy | Likely benign (Jun 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217498
- GRCh38:
- Chr9:36217501
| GNE | I678T, I709T, I568T, I627T, I604T, I619T | Sialuria, GNE myopathy | Uncertain significance (Jun 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217422
- GRCh38:
- Chr9:36217425
| GNE | D629E, D734E, D703E, D593E, D644E, D652E | Sialuria, GNE myopathy | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246023
- GRCh38:
- Chr9:36246026
| GNE | | Sialuria, GNE myopathy | Uncertain significance (Mar 4, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246200
- GRCh38:
- Chr9:36246203
| GNE | | Sialuria, GNE myopathy | Likely benign (Sep 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217480
- GRCh38:
- Chr9:36217483
| GNE | R684H, R625H, R574H, R610H, R715H, R633H | Sialuria, GNE myopathy | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236944
- GRCh38:
- Chr9:36236947
| GNE | | GNE myopathy, Sialuria | Likely benign (Oct 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36219902
- GRCh38:
- Chr9:36219905
| GNE | | GNE myopathy, Sialuria | Likely benign (Oct 10, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36227237
- GRCh38:
- Chr9:36227240
| GNE | | Sialuria, GNE myopathy | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246170
- GRCh38:
- Chr9:36246173
| GNE | | GNE myopathy, Sialuria | Likely benign (Sep 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36246259
- GRCh38:
- Chr9:36246262
| GNE | R129G, R160G, R70G | Sialuria, GNE myopathy | Uncertain significance (Sep 26, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36220030
- GRCh38:
- Chr9:36220033
| GNE | | Sialuria, GNE myopathy | Uncertain significance (Sep 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249276-36249277
- GRCh38:
- Chr9:36249279-36249280
| GNE | A26F, A57F | Sialuria, GNE myopathy | Uncertain significance (Dec 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236819
- GRCh38:
- Chr9:36236822
| GNE | | Sialuria, GNE myopathy | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36218232
- GRCh38:
- Chr9:36218235
| GNE | | GNE myopathy, Sialuria | Likely benign (Aug 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36249371
- GRCh38:
- Chr9:36249374
| GNE | | GNE myopathy, Sialuria | Likely benign (Sep 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36220027
- GRCh38:
- Chr9:36220030
| GNE | | GNE myopathy, Sialuria | Likely benign (Dec 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36218186-36218187
- GRCh38:
- Chr9:36218189-36218190
| GNE | | Sialuria, GNE myopathy | Pathogenic (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36234015
- GRCh38:
- Chr9:36234018
| GNE | G326V, G236V, G185V, G244V, G295V | Sialuria, GNE myopathy | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36236975
- GRCh38:
- Chr9:36236978
| GNE | D149A, D208A, D239A | Sialuria, GNE myopathy | Uncertain significance (Jul 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36227386-36227387
- GRCh38:
- Chr9:36227389-36227390
| GNE | | Sialuria, GNE myopathy | Pathogenic (Jul 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36234101
- GRCh38:
- Chr9:36234104
| GNE | K157fs, K298fs, K208fs, K267fs, K216fs | GNE myopathy, Sialuria | Pathogenic (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217389
- GRCh38:
- Chr9:36217392
| GNE | | GNE myopathy, Sialuria | Likely benign (Jul 6, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36222762
- GRCh38:
- Chr9:36222765
| GNE | | Sialuria, GNE myopathy | Likely benign (Jun 24, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217426
- GRCh38:
- Chr9:36217429
| GNE | V628D, V592D, V651D, V643D, V702D, V733D | Sialuria, GNE myopathy | Uncertain significance (Jul 3, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36276915
- GRCh38:
- Chr9:36276918
| GNE | | Sialuria, GNE myopathy | Likely benign (Sep 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223515-36223516
- GRCh38:
- Chr9:36223518-36223519
| GNE | | GNE myopathy, Sialuria | Likely benign (Feb 9, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36229072
- GRCh38:
- Chr9:36229075
| GNE | T370I, T280I, T288I, T339I, T229I | GNE myopathy, Sialuria | Uncertain significance (Sep 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36217593
- GRCh38:
- Chr9:36217596
| GNE | | GNE myopathy, Sialuria | Uncertain significance (Dec 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223516-36223517
- GRCh38:
- Chr9:36223519-36223520
| GNE | | Sialuria, GNE myopathy | Likely benign (Aug 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223511-36223513
- GRCh38:
- Chr9:36223514-36223516
| GNE | | GNE myopathy, Sialuria | Likely benign (Aug 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36234037
- GRCh38:
- Chr9:36234040
| GNE | I229V, I237V, I319V, I178V, I288V | Sialuria, GNE myopathy | Uncertain significance (Jun 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223455
- GRCh38:
- Chr9:36223458
| GNE | | GNE myopathy, Sialuria | Likely benign (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr9:36223516-36223517
- GRCh38:
- Chr9:36223519-36223520
| GNE | | Sialuria, GNE myopathy | Likely benign (Aug 11, 2022) | criteria provided, single submitter |